Association of interleukin-2 therapy with staphylococcal bacteremia.

  title={Association of interleukin-2 therapy with staphylococcal bacteremia.},
  author={Jon M. Richards and Teresa A Gilewski and Nicholas John Vogelzang},
  volume={67 6},
The authors prospectively monitored patients undergoing leukapheresis for peripheral stem cell harvesting (PSCH) or lymphokine activated killer (LAK) cell generation for 3 weeks after catheter placement for evidence of local or systemic infections. Over a 1-year period, 16 patients underwent leukapheresis for PSCH in preparation for autologous bone marrow transplantation (ABMT). The original catheters remained in place an average of 20 days without any documented infections. Seventeen patients… CONTINUE READING